PMID- 17559151 OWN - NLM STAT- MEDLINE DCOM- 20070830 LR - 20161019 IS - 0270-9139 (Print) IS - 0270-9139 (Linking) VI - 46 IP - 2 DP - 2007 Aug TI - Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. PG - 339-49 AB - CD8(+) T cell responses play a key role in governing the outcome of hepatitis C virus (HCV) infection, and viral evolution enabling escape from these responses may contribute to the inability to resolve infection. To more comprehensively examine the extent of CD8 escape and adaptation of HCV to human leukocyte antigen (HLA) class I restricted immune pressures on a population level, we sequenced all non-structural proteins in a cohort of 70 chronic HCV genotype 1a-infected subjects (28 subjects with HCV monoinfection and 42 with HCV/human immunodeficiency virus [HIV] coinfection). Linking of sequence polymorphisms with HLA allele expression revealed numerous HLA-associated polymorphisms across the HCV proteome. Multiple associations resided within relatively conserved regions, highlighting attractive targets for vaccination. Additional mutations provided evidence of HLA-driven fixation of sequence polymorphisms, suggesting potential loss of some CD8 targets from the population. In a subgroup analysis of mono- and co-infected subjects some associations lost significance partly due to reduced power of the utilized statistics. A phylogenetic analysis of the data revealed the substantial influence of founder effects upon viral evolution and HLA associations, cautioning against simple statistical approaches to examine the influence of host genetics upon sequence evolution of highly variable pathogens. CONCLUSION: These data provide insight into the frequency and reproducibility of viral escape from CD8(+) T cell responses in human HCV infection, and clarify the combined influence of multiple forces shaping the sequence diversity of HCV and other highly variable pathogens. FAU - Timm, Joerg AU - Timm J AD - Partners AIDS Research Center, Infectious Disease Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. FAU - Li, Bin AU - Li B FAU - Daniels, Marcus G AU - Daniels MG FAU - Bhattacharya, Tanmoy AU - Bhattacharya T FAU - Reyor, Laura L AU - Reyor LL FAU - Allgaier, Rachel AU - Allgaier R FAU - Kuntzen, Thomas AU - Kuntzen T FAU - Fischer, Will AU - Fischer W FAU - Nolan, Brian E AU - Nolan BE FAU - Duncan, Jared AU - Duncan J FAU - Schulze zur Wiesch, Julian AU - Schulze zur Wiesch J FAU - Kim, Arthur Y AU - Kim AY FAU - Frahm, Nicole AU - Frahm N FAU - Brander, Christian AU - Brander C FAU - Chung, Raymond T AU - Chung RT FAU - Lauer, Georg M AU - Lauer GM FAU - Korber, Bette T AU - Korber BT FAU - Allen, Todd M AU - Allen TM LA - eng GR - P01 AI061734/AI/NIAID NIH HHS/United States GR - AI067926/AI/NIAID NIH HHS/United States GR - R01 AI067926/AI/NIAID NIH HHS/United States GR - P01 AI061734-02/AI/NIAID NIH HHS/United States GR - AI066345/AI/NIAID NIH HHS/United States GR - U19 AI066345/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Hepatology JT - Hepatology (Baltimore, Md.) JID - 8302946 RN - 0 (Epitopes, T-Lymphocyte) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Viral Nonstructural Proteins) SB - IM MH - Amino Acid Sequence MH - CD4 Lymphocyte Count MH - CD8-Positive T-Lymphocytes/*immunology MH - Epitopes, T-Lymphocyte MH - Genes, MHC Class I MH - Hepacivirus/genetics/*immunology MH - Hepatitis C/*immunology MH - Histocompatibility Antigens Class I/*immunology MH - Humans MH - Phylogeny MH - Sequence Alignment MH - Viral Nonstructural Proteins/*chemistry EDAT- 2007/06/15 09:00 MHDA- 2007/08/31 09:00 CRDT- 2007/06/15 09:00 PHST- 2007/06/15 09:00 [pubmed] PHST- 2007/08/31 09:00 [medline] PHST- 2007/06/15 09:00 [entrez] AID - 10.1002/hep.21702 [doi] PST - ppublish SO - Hepatology. 2007 Aug;46(2):339-49. doi: 10.1002/hep.21702.